이오플로우
294090KOSDAQ의료용 기기 제조업56.5 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
EoFlow is a medical device company established in 2011, specializing in wearable insulin pumps using electroosmotic pump technology. It launched the disposable wearable insulin pump EOPatch in 2021, which offers superior convenience, waterproofing, and longer replacement intervals compared to existing products, securing a competitive edge in the diabetes medical device market. The company expanded into European markets in 2022 and is exploring diverse fields such as obesity and NASH treatments through non-insulin pump business. However, its non-insulin business has been halted due to a lawsuit with Insulet.
Number of Employees
51people
Average Salary
55.0M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Avg ▼25.4% (2-year basis)
Avg ▲4.3% (2-year basis)
Avg ROE -140.2% (declining, 2yr)
Detailed News Sentiment
- Neutral이오플로우, 30억 규모 전환사채권 발행 결정
이오플로우가 운영자금 조달을 위해 30억원 규모의 5회차 무기명식 이권부 무보증 사모 전환사채 발행을 결정했다.
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Neutral기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)2026-04-10
- Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-04-07
- Neutral[기재정정]정기주주총회결과2026-04-01
- Neutral주주명부폐쇄기간또는기준일설정2026-04-01
- Neutral주주총회소집결의2026-04-01
